Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Sulfonylureas as Concomitant Insulin Secretagogues and NLRP3 Inflammasome Inhibitors
HTML
Details
Locations
Year:
2017
Type:
article
Source:
ChemMedChem
DOI:
10.1002/cmdc.201700270
Authors:
James R. Hill,
Rebecca C. Coll,
Nancy Sue,
Janet C. Reid,
Jennifer Dou,
Caroline L. Holley,
Ruby Pelingon,
Joshua B. Dickinson,
Trevor J. Biden,
Kate Schroder,
Matthew A. Cooper,
Avril A. B. Robertson
show all 12
Institutions:
The University of Queensland,
Institute for Molecular Bioscience,
Garvan Institute of Medical Research
Language:
English
Topic:
Inflammasome and immune disorders
Subfield:
Molecular Biology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
sulfonylureas,
NLRP3 inflammasome inhibition,
insulin secretion,
type 2 diabetes,
pancreatic beta-cell destruction,
IL-1β,
bone marrow-derived macrophages,
MIN6 cells,
drug synthesis,
inflammation in diabetes
show all 10
SDG:
Good health and well-being
Open Access status:
closed
Funders:
University of Queensland,
Australian Research Council,
National Health and Medical Research Council,
Australia-India Strategic Research Fund
Awards:
New antibiotics and treatment methods against drug-resistant bacteria,
Inflammasomes: molecular drivers of anti-microbial defence,
Inhibitors of NLRP3 activation for treatment of inflammatory CNS diseases,
G4769032348
OpenAlex ID:
W2735069880
FWCI:
1.686
Cites:
52
Cited by:
67
Related to:
10